Press release
Global NMDA Receptor Antagonist Market Research Report 2023 to 2028
NMDA receptor antagonists are a class of drugs that block the activity of the N-methyl-D-aspartate (NMDA) receptor, which is involved in excitatory neurotransmission in the brain. While NMDA receptor antagonists have primarily been studied and used in conditions like depression and schizophrenia, there is emerging research exploring their potential in Parkinson's disease and Alzheimer's disease. However, it's important to note that the use of NMDA receptor antagonists in these conditions is still investigational, and no specific drugs in this class have been approved for the treatment of Parkinson's disease or Alzheimer's disease.
In Parkinson's disease, research suggests that NMDA receptor antagonists may have neuroprotective effects and potentially reduce the motor symptoms associated with the condition. The excessive activation of NMDA receptors can lead to an influx of calcium ions and subsequent neuronal damage, which is believed to contribute to the progression of Parkinson's disease. By blocking NMDA receptors, antagonists may help regulate the calcium influx and provide neuroprotection. However, more research is needed to determine the effectiveness and safety of NMDA receptor antagonists in Parkinson's disease.
In Alzheimer's disease, the role of NMDA receptor antagonists is more complex. Alzheimer's disease involves the accumulation of beta-amyloid plaques and the formation of neurofibrillary tangles, which lead to neuronal dysfunction and cognitive decline. NMDA receptor antagonists may help by modulating glutamate activity, as excessive glutamate release can be toxic to neurons and contribute to neurodegeneration. By blocking NMDA receptors, antagonists can potentially reduce the excitotoxicity associated with Alzheimer's disease. However, clinical trials investigating NMDA receptor antagonists in Alzheimer's disease have shown mixed results, and more research is necessary to determine their efficacy.
It's important to recognize that the treatment of Parkinson's disease and Alzheimer's disease is complex and multifaceted. Current standard therapies involve a combination of medications, rehabilitation strategies, and supportive care.
Market Share Analysis
The North American market for NMDA Receptor Antagonist is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
Asia-Pacific market for NMDA Receptor Antagonist is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2022 through 2028.
The major global manufacturers of NMDA Receptor Antagonist include Algernon Pharmaceuticals, Relmada Therapeutics, UCB, Avanir Pharmaceuticals, Axsome Therapeutics, Seelos Therapeutics, PharmaTher, Cessatech and ATAI Life Sciences, etc. In 2021, the world's top three vendors accounted for approximately % of the revenue.
View full Report
https://reports.valuates.com/market-reports/QYRE-Auto-26P12399/global-nmda-receptor-antagonist
NMDA Receptor Antagonist segment by Type
• Vaccine
• Monoclonal Antibody
• Application Insights
NMDA Receptor Antagonist segment by Application
• Parkinson's Disease
• Alzheimer's Disease
• Others
BY REGION
• North America
• Europe
• Asia-Pacific
• Latin America
• Middle East & Africa
Get Free Sample:
https://reports.valuates.com/request/sample/QYRE-Auto-26P12399/Global_NMDA_Receptor_Antagonist_Market_Research_Report_2022
Similar Report
https://reports.valuates.com/market-reports/QYRE-Auto-3X6204/global-dextromethorphan
https://reports.valuates.com/market-reports/QYRE-Auto-0L14683/global-memantine-hcl-api
https://reports.valuates.com/market-reports/QYRE-Auto-34V12824/global-alzheimer-s-treatment-drugs
https://reports.valuates.com/reports/QYRE-Auto-29S2943/global-orphan-drugs
Valuates Reports
sales@valuates.com
For U.S. Toll-Free Call 1-(315)-215-3225
For IST Call +91-8040957137
WhatsApp: +91-9945648335
Website: https://reports.valuates.com
Twitter - https://twitter.com/valuatesreports
Valuates offers in-depth market insights into various industries. Our extensive report repository is constantly updated to meet your changing industry analysis needs.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global NMDA Receptor Antagonist Market Research Report 2023 to 2028 here
News-ID: 3101631 • Views: …
More Releases from Valuates Reports
Railway Wheelsets Market Size, Trends & Forecasts | Valuates Reports
Railway Wheelsets Market Size
The global market for Railway Wheelsets was valued at US$ 3441 million in the year 2024 and is projected to reach a revised size of US$ 4481 million by 2031, growing at a CAGR of 3.9% during the forecast period.
Get Free Sample: https://reports.valuates.com/request/sample/QYRE-Auto-15G5075/Global_Railway_Wheelsets_Market_Insights_Forecast_to_2028?utm_source=openpr&utm_medium=referral
According to the data of China Association of Metros, by the end of 2022, 55 cities in mainland China have opened urban rail transit and…
Wheel Service Equipment Market Size, Trends & Forecasts | Valuates Reports
Wheel and tyre service equipment are the basic requirement of every garage or workshop to serve their clients at its best.
Market Analysis and Insights: Global Wheel Service Equipment Market
Global Wheel Service Equipment market size is estimated to be worth US$ 683.7 million in 2022 and is forecast to a readjusted size of US$ 816.3 million by 2028 with a CAGR of 3.0% during the review period.
Get Free Sample: https://reports.valuates.com/request/sample/QYRE-Auto-9F9222/Global_Wheel_Service_Equipment_Market_Insights_and_Forecast_to_2028?utm_source=openpr&utm_medium=referral
Fully considering…
Wheel Hub Oil Seal Market Size, Trends & Forecasts | Valuates Reports
Wheel Hub Oil Seal Market Size
The global market for Wheel Hub Oil Seal was valued at US$ 968 million in the year 2024 and is projected to reach a revised size of US$ 1422 million by 2031, growing at a CAGR of 5.7% during the forecast period.
Get Free Sample: https://reports.valuates.com/request/sample/QYRE-Auto-11J19500/Global_Wheel_Hub_Oil_Seal_Market_Research_Report_2025?utm_source=openpr&utm_medium=referral
The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent…
Wheel Bearing Seal Market Size, Trends & Forecasts | Valuates Reports
Wheel Bearing Seal Market Size
The global market for Wheel Bearing Seal was valued at US$ 309 million in the year 2024 and is projected to reach a revised size of US$ 400 million by 2031, growing at a CAGR of 3.8% during the forecast period.
Get Free Sample: https://reports.valuates.com/request/sample/QYRE-Auto-19S11648/Global_Wheel_Bearing_Seal_Market_Research_Report_2022?utm_source=openpr&utm_medium=referral
Wheel Bearing Seal mainly refers to Wheel end seals, which are a type of automotive seals. Automotive seals are divided into bearing seals,…
More Releases for NMDA
Rapid-acting Antidepressants (NMDA receptor modulators) Market Size, Clinical Tr …
Rapid-acting Antidepressants (NMDA receptor modulators) Market Size is estimated to be $3560 million in 2024 and is expected to grow at an average yearly rate of around 8% during the timeframe (2025-2032).
What is Rapid-acting Antidepressants (NMDA receptor modulators) and what are the growth drivers of Rapid-acting Antidepressants (NMDA receptor modulators) Market?
Rapid-acting antidepressants (RAADs) are a class of novel therapeutics designed to alleviate symptoms of depression within hours or…
Significant Investment Secured to Advance Precision Medicine for Anti-NMDA Recep …
"What Is the Expected Size and Growth Rate of the Encephalitis Treatment Market?
The encephalitis treatment market has grown strongly in recent years. It will expand from $21.09 billion in 2024 to $22.38 billion in 2025, at a compound annual growth rate (CAGR) of 6.1%. The growth is driven by the high incidence of encephalitis, the prevalence of viral or bacterial infections, government initiatives, and the rising demand for preventive encephalitis…
Significant Investment Secured to Advance Precision Medicine for Anti-NMDA Recep …
What Is the Expected Size and Growth Rate of the Encephalitis Treatment Market?
The encephalitis treatment market has grown strongly in recent years. It will expand from $21.09 billion in 2024 to $22.38 billion in 2025, at a compound annual growth rate (CAGR) of 6.1%. The growth is driven by the high incidence of encephalitis, the prevalence of viral or bacterial infections, government initiatives, and the rising demand for preventive encephalitis…
Glutamate Receptor Ionotropic NMDA 2B Market to Witness Huge Growth by 2027 Covi …
A huge collection of procedures and actions are documented in this Glutamate Receptor Ionotropic NMDA 2B market analysis to help organization take sound and smart decision. Prioritized information presented here makes the task of understanding latest market scenario with ease. It captures competition level and market size for the projected years 2021-2027. It focuses on market segmentation according to region, type and end-use. It further aims at gathering important data…
Neuroprotective Products Market Is Expected To Grow At A Rapid Pace Throughout B …
Acumen Research and Consulting has announced the addition of the "Neuroprotective Products Market” report to their offering.
The Neuroprotective Products Market Report 2018 is an in depth study analyzing the current state of the Neuroprotective Products Market. It provides brief overview of the market focusing on definitions, market segmentation, end-use applications and industry chain analysis. The study on Neuroprotective Products Market provides analysis of China market covering the industry trends, recent…
Anti-Suicide Drugs Market Report 2018: Segmentation by Chemistry Type (Anti-Depr …
Global Anti-Suicide Drugs market research report provides company profile for Pfizer, Inc., AstraZeneca plc, Eli Lilly and Company, Allergan plc, GlaxoSmithKline plc, Merck & Co., Inc., H. Lundbeck A/S, NeuroRx, Inc., Johnson & Johnson and Others.
This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue, YOY growth rate,…
